Winsan (Shanghai) Medical Science and Technology Co., Ltd. (SHSE:600767) signed a share transfer agreement to acquire remaining 16% stake in Jingde Honglin Health Industry Development Co., Ltd. from Wang Longfa for CNY 11 million on May 10, 2019. Post acquisition, Winsan (Shanghai) Medical Science and Technology Co., Ltd. will hold 100% stake in Jingde Honglin Health Industry Development Co., Ltd. As of December 31, 2018, Jingde Honglin Health Industry Development Co., Ltd. reported total assets of approximately CNY 100 million, net assets of CNY 60 million, revenue of CNY 3.7 million and net profit of CNY 0.7 million. On May 10, 2019, Winsan (Shanghai) Medical Science and Technology Co., Ltd. held its 9th directorate’s 14th meeting and its 9th Supervisory Board’s 11th meeting and approved the acquisition. Winsan (Shanghai) Medical Science and Technology Co., Ltd. (SHSE:600767) cancelled the acquisition of remaining 16% stake in Jingde Honglin Health Industry Development Co., Ltd. from Wang Longfa on May 10, 2020.